SPYRE THERAPEUTICS, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2016 | -34.5% | -34.5% | -32.4% |
| FY2017 | -54.1% | -54.1% | -48.6% |
| FY2018 | -65.8% | -65.8% | -57.0% |
| FY2019 | -130.2% | -130.2% | -94.1% |
| FY2020 | -57.9% | -57.9% | -50.1% |
| FY2021 | -78.4% | -78.4% | -59.9% |
| FY2022 | -166.6% | -166.6% | -117.8% |
| FY2023 | -184.1% | -184.1% | -99.1% |
| FY2024 | -40.2% | -40.2% | -34.2% |
| FY2025 | -21.7% | -21.7% | -20.0% |